دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 4,800,000 تومان- قیمت ویژه : 2,400,000تومان
پکیج دسترسی ۳ ماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 93 ﺭﻭﺯ
قیمت : 1,500,000 تومان- قیمت ویژه : 750,000تومان
Greetings from the Editor – 2025
doi : 10.1016/j.ard.2025.01.001
Volume 84, Issue 1, January 2025, Pages 1-4
Bridging the gap: tackling the challenge of limited progressors in clinical trials aimed at slowing the transition from early preradiographic to established osteoarthritis
Microbiome research in autoimmune and immune-mediated inflammatory diseases: lessons, advances and unmet needs
doi : 10.1136/ard-2024-225735
Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease
doi : 10.1136/ard-2023-224211
EULAR recommendations for the treatment of systemic sclerosis: 2023 update
doi : 10.1136/ard-2024-226430
Association of methotrexate polyglutamates concentration with methotrexate efficacy and safety in patients with rheumatoid arthritis treated with predefined dose: results from the MIRACLE trial
doi : 10.1136/ard-2024-226350
Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial
doi : 10.1136/ard-2024-226620
Performance analysis of a deep-learning algorithm to detect the presence of inflammation in MRI of sacroiliac joints in patients with axial spondyloarthritis
doi : 10.1136/ard-2024-225862
Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial
doi : 10.1136/ard-2024-226286
Results from the international collaborative systematic literature review informing the 2023 EULAR recommendations for the treatment of systemic sclerosis
doi : 10.1136/ard-2024-226429
Lupus and inflammatory bowel disease share a common set of microbiome features distinct from other autoimmune disorders
doi : 10.1136/ard-2024-225829
Comparison of definitions of early knee osteoarthritis for likelihood of progression at 2-year and 5-year follow-up: the Multicenter Osteoarthritis Study
doi : 10.1136/ard-2024-226060
Predicting rapid progression in knee osteoarthritis: a novel and interpretable automated machine learning approach, with specific focus on young patients and early disease
doi : 10.1136/ard-2024-225872
Relationship between serum urate and changes in dual-energy CT monosodium urate crystal volume over 1 year in people with gout: an individual participant data analysis
doi : 10.1136/ard-2024-226059
Assessing the performance of AI chatbots in answering patients' common questions about low back pain
doi : 10.1136/ard-2024-226202
Greetings from the Editor – 2025
doi : 10.1016/j.ard.2025.01.001
Volume 84, Issue 1, January 2025, Pages 1-4
Bridging the gap: tackling the challenge of limited progressors in clinical trials aimed at slowing the transition from early preradiographic to established osteoarthritis
Microbiome research in autoimmune and immune-mediated inflammatory diseases: lessons, advances and unmet needs
doi : 10.1136/ard-2024-225735
Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease
doi : 10.1136/ard-2023-224211
EULAR recommendations for the treatment of systemic sclerosis: 2023 update
doi : 10.1136/ard-2024-226430
Association of methotrexate polyglutamates concentration with methotrexate efficacy and safety in patients with rheumatoid arthritis treated with predefined dose: results from the MIRACLE trial
doi : 10.1136/ard-2024-226350
Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial
doi : 10.1136/ard-2024-226620
Performance analysis of a deep-learning algorithm to detect the presence of inflammation in MRI of sacroiliac joints in patients with axial spondyloarthritis
doi : 10.1136/ard-2024-225862
Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial
doi : 10.1136/ard-2024-226286
Results from the international collaborative systematic literature review informing the 2023 EULAR recommendations for the treatment of systemic sclerosis
doi : 10.1136/ard-2024-226429
Lupus and inflammatory bowel disease share a common set of microbiome features distinct from other autoimmune disorders
doi : 10.1136/ard-2024-225829
Comparison of definitions of early knee osteoarthritis for likelihood of progression at 2-year and 5-year follow-up: the Multicenter Osteoarthritis Study
doi : 10.1136/ard-2024-226060
Predicting rapid progression in knee osteoarthritis: a novel and interpretable automated machine learning approach, with specific focus on young patients and early disease
doi : 10.1136/ard-2024-225872
Relationship between serum urate and changes in dual-energy CT monosodium urate crystal volume over 1 year in people with gout: an individual participant data analysis
doi : 10.1136/ard-2024-226059
Assessing the performance of AI chatbots in answering patients' common questions about low back pain
doi : 10.1136/ard-2024-226202
